FinnCap reissued their corporate rating on shares of ANGLE plc (LON:AGL) in a report issued on Monday morning, Marketbeat.com reports. The brokerage currently has a GBX 100 ($1.31) price target on the stock, down from their previous price target of GBX 108 ($1.42).
Separately, Beaufort Securities reaffirmed a speculative buy rating on shares of ANGLE plc in a research note on Wednesday, July 5th.
Shares of ANGLE plc (LON AGL) opened at 43.00 on Monday. The stock’s market cap is GBX 31.54 million. The firm has a 50 day moving average of GBX 36.80 and a 200 day moving average of GBX 48.47. ANGLE plc has a one year low of GBX 32.27 and a one year high of GBX 80.00.
COPYRIGHT VIOLATION NOTICE: This report was posted by Community Financial News and is the sole property of of Community Financial News. If you are accessing this report on another website, it was illegally stolen and republished in violation of international copyright laws. The correct version of this report can be read at https://www.com-unik.info/2017/10/13/angle-plc-agl-earns-corporate-rating-from-finncap.html.
ANGLE plc Company Profile
ANGLE plc is a holding company. The Company’s principal activity is undertaken in relation to the commercialization of its Parsortix cell separation system, with deployment in non-invasive cancer diagnostics. The Company is a specialist medical diagnostic company, which offers products for cancer diagnostics and fetal health.
What are top analysts saying about ANGLE plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for ANGLE plc and related companies.